Skip to main content

Table 1 Detailed description of included studies

From: The hypotensive effect of salt substitutes in stage 2 hypertension: a systematic review and meta-analysis

Author

Year

Design of studies

Country

No. of Subjects in case group

No. of controls

Age of intervention group (mean)

Follow-up Duration (week)

Clinical Condition

Salt substitute

Salt type

Baseline BP

Quality

sex

method of measurement

Allaert

2013

a randomized, placebo-controlled, double-blind, clinical trial crossover study.

France

21

19

58.6(Total)

8 weeks

Stage 2 of hypertension

NaCl + Chitosan 3%

NaCl

149.2/93.4

3

m/f

Blood pressure was measured using homologated automated digital sphygmomanometers.

The BP cuff was placed around the upper left arm which was supported at the level of the heart while the subject sat in a chair. Blood pressure was measured after a 10-min rest and preferably at three different times separated by 3-min intervals. The average of the three measurements was calculated.

Arzilli

1986

Randomized controlled trial

Italy

5

5

39.5(Total)

0.25 months

Stage 2 of hypertension

k/Na salt

Common salt [N/A]

> 95

 

m/f

NS

Barros

2015

Single-blind randomized controlled trial

Brazil

19

16

55.5(total participants)

4 weeks

Stage 2 of hypertension

130 mg of sodium, 346 mg of potassium and 44 mcg ofiodine for per gram light salt

390 mg of sodium and 25 mcg of iodine per gram salt

142.95/89.79

5

m/f

Casual BP was measured by the researcher. And home blood pressure use in this study

Gilleran

1996

a randomised blind controlled parallel study.

United kingdom

20

20

62.5

3 months

Stage 2 of hypertension and Type II diabetic

50% NaCl, 40% KCL, 10% Mg2+

Ordinary Table salt [N/A]

Sbp = 163.2

NS

m/f

NS

Pereira

2005

randomized, double-blind

Brazil

12

10

47.5(Total)

12 week

Stage 2 of hypertension

50% sodium chloride and 50% potassium chloride

NaCl100%

136.2/93.8

4

m/f

Systolic and diastolic blood pressure values during medical consultation were determined by the auscultatory method. Measurements were made with the cuff placed covering the two thirds on the upper arm with the patient sitting, after 5 min at rest, and the values of systolic and diastolic pressure

Sarkkinen

2011

Randomized, double-blind, placebo-controlled

Finland

22

23

57

8 week

Stage 2 of hypertension

50% sodium chloride (NaCl), 25% potassium chloride(KCl) and 25% magnesal; magnesium ammonium potassiumchloride, hydrate [Mg4K(NH4)3Cl12·24H2O]

NaCl100%

140/89

4

m/f

BP and heart rate were measured using an automatic sphygmomanometer (Omron M4-I, fully automatic BP monitor, Omron Matsusaka Co, Ltd., Japan) following 10 min rest in a sitting position. BP was measured three times with intervals of at least two minutes, between the hours of 7:00 am and 12:00 noon. BP was measured using the non-dominant arm with the exception of the first study visit during which BP was measured using both arms. If the BP in the two arms differed in SBP or DBP by more than 10 mmHg, the arm with the higher reading was used for all subsequent measurements. Volunteers were not told the results of their BP measurements during the study and the study nurse was unaware of the treatment allocations

Yang (a)

2018

Single blind, randomized, controlled trial

China

24

27

67.8

6 months

Stage 2 of hypertension

Low sodium salt [Nacl65%, Kcl30%, Ca salts5% and 12 mg/kg folic acid]

NaCl100%

161/80.6

 

m/f

SBP and DBP were defined by Korotkoff sound phase 1 and phase 5, respectively.

Yang (b)

2018

Single blind, randomized, controlled trial

China

38

37

67.3

6 months

Stage 2 of hypertension

Low sodium salt [Nacl65%, Kcl30%, Ca salts5% and 12 mg/kg folic acid]

NaCl100%

159/85

 

m/f

SBP and DBP were defined by Korotkoff sound phase 1 and phase 5, respectively.

Zhao

2014

Patient-Blinded Randomized Controlled Trial

China

99

114

62.8

3 months

Stage 2 of hypertension

65% sodium chloride, 25%potassium chloride and 10% magnesium sulfate

NaCl100%

174.1/102.2

5

m/f

Blood pressure was measured with three consecutive blood pressure measurements (with at least one minute’s rest between each measurement) from a seated subjects’ right arm in a quiet room. A previously validated electronic sphygmomanometer (OMRON HEM-759P, Dalian China) was used.

Zhou

2009

Single-blind, randomized, controlled trial

China

62

64

67.5

6 months

Stage 2 of hypertension

NaCl, 65%;

KCl, 30%;

Calcium saits 5%;

12 mg/kg folic acid

NaCl100%

159.7/83.3

4

m/f

the measurement were performed by two experienced physicians

Zhou

2013

Double-blind, randomized controlled trial

China

224

238

46(Total)

24 months

Stage 2 of hypertension

NaCl, 65%;

KCl, 25%;

MgSO4, 10%

NaCl100%

154/91

5

m/f

Blood pressure was measured at each visit by trained doctors using an Omron HEM-770A automatic sphygmomanometer (OMRON (China) Co., Ltd. (OCE/OCE-HCB/OCE-SH), Shanghai, China). Blood pressure was measured in the right arm at the heart level in the seated position.